OnabotulinumtoxinA for primary new daily persistent headache and comparison to chronic migraine. Cheema S, Lagrata S, Rantell KR, Ahmed M, et al. Cephalalgia 2025;45:3331024251317448.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cheema S, Lagrata S, Rantell KR, Ahmed M, et al. OnabotulinumtoxinA for primary new daily persistent headache and comparison to chronic migraine. Cephalalgia 2025;45:3331024251317448.
PMID: 39924901